Antimicrobials

Top Story

Treatment of acute rhinosinusitis difficult because of increasing antimicrobial resistance

June 22, 2017

MS, APRN, FNP,PHILADELPHIA — Antimicrobial resistance to all Streptococcus pneumoniae has been estimated at 30% to 40% for products such as erythromycin and azithromycin, and rising fluoroquinolone resistance has made treating bacterial cases more difficult, according to a recent presentation at the annual meeting of the American Association of Nurse Practitioners.

“This is frightening because in my world, and in [many practitioner’s] worlds, this is the best class of antibiotic we have from a spectrum perspective,” Wendy L. Wright, MS, APRN, FNP, said in her presentation. “They have side effects, but if I need to treat particular infections, this is the best drug we have for many people on an outpatient basis.”

Editorial

Code red for MDR bacteria: Resistance to carbapenems doubles in ICUs

Infectious Disease News, June 2017
Thomas P. Lodise, MD
Four years ago, the CDC’s Antibiotic Resistance Threats in the United States report warned that inaction could have “potentially catastrophic…
In the Journals

E coli, GBS responsible for 64% of neonatal bacterial meningitis

June 21, 2017
Bacterial meningitis contracted within the first 90 days of life was most commonly attributed to infection from Escherichia coli and group B Streptococcus, each…
In the Journals

Awareness of patient harm increases physician support of fines for antibiotic overprescribing

June 20, 2017
Physician support of financial penalties for inappropriate antibiotic prescribing varied by whether patient, societal or institutional harms were presented as the…
CME

HPV Immunization: Ensuring Your Patients Do Not Slip through the Cracks

This activity is supported by an educational grant from Merck & Co., Inc.

Vaccination rates for the human papillomavirus (HPV) continue to be below those of other vaccines recommended for…
More »
Meeting News

Cefiderocol active against gram-negative drug-resistant pathogens

June 9, 2017
NEW ORLEANS — A late-stage investigational drug penetrates a variety of gram-negative pathogens and could be a…
More »
Featured
ASM Microbe

ASM Microbe

Video
Meeting News

VIDEO: Early antibiotic therapy, risk stratification improves patient outcomes

November 13, 2016
More »
Meeting News

Treatment of acute rhinosinusitis difficult because of increasing antimicrobial resistance

June 22, 2017
MS, APRN, FNP,PHILADELPHIA — Antimicrobial resistance to all Streptococcus pneumoniae has been estimated at 30% to 40% for products…

Editorial

Code red for MDR bacteria: Resistance to carbapenems doubles in ICUs

Infectious Disease News, June 2017
Thomas P. Lodise, MD
Four years ago, the CDC’s Antibiotic Resistance Threats in the United States report warned that inaction could have “potentially…

In the Journals

E coli, GBS responsible for 64% of neonatal bacterial meningitis

June 21, 2017
Bacterial meningitis contracted within the first 90 days of life was most commonly attributed to infection from Escherichia coli and group B…

In the Journals

Awareness of patient harm increases physician support of fines for antibiotic overprescribing

June 20, 2017
Physician support of financial penalties for inappropriate antibiotic prescribing varied by whether patient, societal or institutional harms were…

FDA News

FDA approves Baxdela for treatment of ABSSSIs

June 20, 2017
The FDA recently approved an IV and oral formulation of Baxdela, an anionic fluoroquinolone, for the treatment of acute bacterial skin and skin…

FDA News

Alvogen recalls clindamycin vials after possible contamination

June 19, 2017
The vials, intended for the hospital and retail level, were recalled after microbial growth was found during a routine manufacturing simulation

In the Journals Plus

Beta-lactam testing in antimicrobial stewardship increases use of preferred antibiotics

June 14, 2017
Using beta-lactam allergy skin testing in antimicrobial stewardship programs significantly increased the use of preferred therapies without

Meeting News

Zerbaxa active against P. aeruginosa in vitro

June 13, 2017
NEW ORLEANS — Zerbaxa is effective in vitro against multidrug-resistant Pseudomonas aeruginosa, one of WHO’s top three pathogens for…

In the Journals

Consider adverse drug events before prescribing antibiotics

June 12, 2017
Common antibiotic-associated adverse drug events can be avoided with more judicious prescribing and therefore, should be considered when initiating…

Meeting News

Lefamulin effective in vitro against CABP, other respiratory infections

June 12, 2017
NEW ORLEANS — Lefamulin, an investigational drug now in phase 3 trials, is effective in vitro against bacterial pneumonia and other respiratory…

More Headlines »
Advertisement
Advertisement